Allstate Corporation’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,319
| Closed | -$426K | – | 730 |
|
|
2021
Q2 | $426K | Hold |
2,319
| – | – | 0.01% | 565 |
|
|
2021
Q1 | $355K | Buy |
2,319
+422
| +22% | +$64.6K | 0.01% | 629 |
|
|
2020
Q4 | $296K | Buy |
1,897
+87
| +5% | +$13.6K | 0.01% | 624 |
|
|
2020
Q3 | $207K | Sell |
1,810
-3,801
| -68% | -$435K | 0.01% | 647 |
|
|
2020
Q2 | $630K | Buy |
+5,611
| New | +$630K | 0.02% | 367 |
|
|
2019
Q4 | – | Sell |
-3,662
| Closed | -$359K | – | 655 |
|
|
2019
Q3 | $359K | Sell |
3,662
-5,640
| -61% | -$553K | 0.01% | 454 |
|
|
2019
Q2 | $1.22M | Buy |
9,302
+377
| +4% | +$49.4K | 0.02% | 371 |
|
|
2019
Q1 | $1.21M | Buy |
8,925
+6,249
| +234% | +$844K | 0.03% | 285 |
|
|
2018
Q4 | $261K | Buy |
+2,676
| New | +$261K | 0.01% | 366 |
|
|
2017
Q2 | – | Sell |
-14,957
| Closed | -$1.81M | – | 320 |
|
|
2017
Q1 | $1.81M | Sell |
14,957
-26,213
| -64% | -$3.18M | 0.11% | 129 |
|
|
2016
Q4 | $5.04M | Buy |
+41,170
| New | +$5.04M | 0.3% | 104 |
|